| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $444.7M | +11.9% |
| Cost of Revenue | $67.6M | — |
| R&D Expense | $44.8M | +22.1% |
| SG&A Expense | $125.1M | +118.4% |
| Operating Income | $51.3M | -58.7% |
| Interest Expense | $38.4M | +16.3% |
| Pre-tax Income | $18.1M | -81.4% |
| Income Tax | $4.4M | +109.1% |
| Net Income | $13.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.8M | -70.0% |
| Accounts Receivable | $111.5M | +131.2% |
| Inventory | $97.9M | +55.0% |
| Current Assets | $323.1M | +2.7% |
| Total Assets | $1.23B | +57.3% |
| Current Liabilities | $182.0M | +152.8% |
| Long-term Debt | $831.6M | +41.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $41.4M | -47.5% |
| Capital Expenditures | $13.5M | -17.0% |
| Investing Cash Flow | -$337.2M | -1229.4% |
| Financing Cash Flow | $198.7M | +265.0% |
| Free Cash Flow | $27.9M | -55.5% |
| -90.6% |
| EPS (Basic) | $0.11 | -90.2% |
| EPS (Diluted) | $0.10 | -90.8% |
| Total Liabilities |
| $1.16B |
| +56.6% |
| Stockholders' Equity | $69.3M | +70.2% |